Making an "Obese" Brain (and Body) Lean: Insulin Detemir, Monoamines, and Reward.

Trial Profile

Making an "Obese" Brain (and Body) Lean: Insulin Detemir, Monoamines, and Reward.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms INDIOM
  • Most Recent Events

    • 17 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 17 Apr 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
    • 24 Jun 2015 Planned End Date changed from 1 Jan 2014 to 1 Dec 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top